This report examines how AI and robotics are transforming pharmaceutical manufacturing under GMP regulations. It covers applications across drug discovery, biopharmaceutical production, sterile fill-finish operations, packaging, quality inspection, intralogistics, and predictive maintenance. Real-world examples illustrate gains in throughput, quality, compliance, and labor productivity through technologies such as robotic laboratories, machine vision inspection, autonomous mobile robots, AI-driven process control, and predictive analytics. The report also evaluates return on investment, showing how automation can reduce defects, lower maintenance costs, improve operational efficiency, enhance traceability, and deliver payback within relatively short timeframes while supporting the industry's move toward smart manufacturing.

Join for free to read